SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-20-145086
Filing Date
2020-05-18
Accepted
2020-05-18 16:38:05
Documents
9
Period of Report
2020-06-29
Effectiveness Date
2020-05-18

Document Format Files

Seq Description Document Type Size
1 DEF 14A d868083ddef14a.htm DEF 14A 875441
2 GRAPHIC g868083g01k50.jpg GRAPHIC 40419
3 GRAPHIC g868083g23k68.jpg GRAPHIC 26481
4 GRAPHIC g868083g25m69.jpg GRAPHIC 107072
5 GRAPHIC g868083g31v61.jpg GRAPHIC 166724
6 GRAPHIC g868083g53d28.jpg GRAPHIC 44917
7 GRAPHIC g868083g55j41.jpg GRAPHIC 111476
8 GRAPHIC g868083g64n91.jpg GRAPHIC 46696
9 GRAPHIC g868083g67y51.jpg GRAPHIC 198048
  Complete submission text file 0001193125-20-145086.txt   1899390
Mailing Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129
Business Address ONE FIRST AVENUE PARRIS BUILDING 34, NAVY YARD PLAZA BOSTON MA 02129 617-259-1970
ZIOPHARM ONCOLOGY INC (Filer) CIK: 0001107421 (see all company filings)

IRS No.: 841475642 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33038 | Film No.: 20890145
SIC: 2834 Pharmaceutical Preparations